NASDAQ: SNYSanofi Earnings & Revenue
SNY past earnings growth
How has SNY's earnings growth performed historically?
Company
375.99%
Industry
14.79%
Market
102.72%
SNY's earnings have grown faster (27.45% per year) than the US Drug Manufacturers - General industry average (14.81%)
Performance
SNY's earnings have grown slower (27.45% per year) than the US market average (27.52%)
Performance
SNY's earnings growth is accelerating - its growth over the last year (375.99%) is above its 5-year compound annual rate (27.45%)
Performance
SNY past revenue growth
How has SNY's revenue growth performed historically?
Company
7.78%
Industry
13.32%
Market
36.32%
SNY's revenue has grown slower (3.78% per year) than the US Drug Manufacturers - General industry average (5.13%)
Performance
SNY's revenue has grown slower (3.78% per year) than the US market average (17.66%)
Performance
SNY's revenue growth is accelerating - its growth over the last year (7.78%) is above its 5-year compound annual rate (3.78%)
Performance
SNY earnings and revenue history
Current Revenue
$45.6B
Current Earnings
$15.0B
Current Profit Margin
33%
SNY's has demonstrated consistent long-term earnings growth over the past 10 years (113.78%)
Performance
SNY Return on equity
Current Company
20.2%
Current Industry
33.4%
Current Market
47.6%
SNY's Return on Equity (20.2%) shows a company that is highly efficient at transforming shareholder equity into returns
Performance
SNY Return on assets
Current Company
10.8%
Current Industry
6.8%
Current Market
5.2%
SNY is generating higher Return on Assets (10.8%) than the US Drug Manufacturers - General industry average (7.27%)
Performance
SNY Return on capital employed
Current Company
15.24%
Current Industry
11%
SNY has gotten more efficient at generating Return on Capital (15.24%) compared to 3 years ago (12.52%)
Performance
Sanofi Earnings & Revenue FAQ
©2021 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.